International — Product revenues, net
Insmed International — Product revenues, net decreased by 10.9% to $35.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.7%, from $28.55M to $35.90M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful international market expansion and growing demand for the company's therapies abroad, while a decrease may signal competitive pressure or regulatory hurdles in those regions.
Detailed definition
This metric represents the total net sales generated from pharmaceutical products within international geographic market...
Peer comparison
Comparable to international segment revenue reported by other global biopharmaceutical companies, often benchmarked against regional growth rates in the rare disease sector.
insm_segment_international_product_revenues_netHistorical Data
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $20.25M | $20.25M | $20.25M | $20.25M | $26.56M | $28.55M | $40.31M | $35.90M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +31.1% | +7.5% | +41.2% | -10.9% |
| YoY Change | — | — | — | — | +31.1% | — | +51.8% | +25.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Insmed's international — product revenues, net?
- Insmed (INSM) reported international — product revenues, net of $35.90M in Q1 2026.
- How has Insmed's international — product revenues, net changed year-over-year?
- Insmed's international — product revenues, net increased by 25.7% year-over-year, from $28.55M to $35.90M.
- What does international — product revenues, net mean?
- The total net sales revenue earned from pharmaceutical products sold in international markets.